MY107811A - Polyamine drug-resin complexes - Google Patents

Polyamine drug-resin complexes

Info

Publication number
MY107811A
MY107811A MYPI91002365A MYPI19912365A MY107811A MY 107811 A MY107811 A MY 107811A MY PI91002365 A MYPI91002365 A MY PI91002365A MY PI19912365 A MYPI19912365 A MY PI19912365A MY 107811 A MY107811 A MY 107811A
Authority
MY
Malaysia
Prior art keywords
drug
cation
polyamine
microns
resin
Prior art date
Application number
MYPI91002365A
Other languages
English (en)
Inventor
Joesph Kelleher William
Earl Carpanzano Anthony
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of MY107811A publication Critical patent/MY107811A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI91002365A 1990-12-21 1991-12-20 Polyamine drug-resin complexes MY107811A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63229090A 1990-12-21 1990-12-21

Publications (1)

Publication Number Publication Date
MY107811A true MY107811A (en) 1996-06-29

Family

ID=24534913

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI91002365A MY107811A (en) 1990-12-21 1991-12-20 Polyamine drug-resin complexes

Country Status (17)

Country Link
EP (1) EP0563294A1 (sk)
JP (1) JPH06504059A (sk)
CN (1) CN1063221A (sk)
AU (1) AU663695B2 (sk)
BR (1) BR9107173A (sk)
CA (1) CA2098200A1 (sk)
CZ (1) CZ119793A3 (sk)
FI (1) FI932842A (sk)
HU (1) HUT74642A (sk)
IE (1) IE914513A1 (sk)
MX (1) MX9102753A (sk)
MY (1) MY107811A (sk)
NO (1) NO932212L (sk)
NZ (1) NZ241097A (sk)
PT (1) PT99912A (sk)
SK (1) SK59493A3 (sk)
WO (1) WO1992011038A1 (sk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005161A1 (en) * 1993-08-13 1995-02-23 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
DE69432867T2 (de) * 1993-11-18 2004-04-22 Sirtex Medical Ltd., Burswood Zubereitung mit gesteuerter freisetzung
ES2097087B1 (es) * 1994-08-01 1997-12-16 Univ Sevilla Sistema de liberacion controlada de morfina y otros farmacos solubles en agua por complejacion con sustancias polimericas.
CA2269679A1 (en) * 1996-12-20 1998-07-02 Warner-Lambert Company Antitussive drugs delivered by partially coated ion exchange resins
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
KR20020016069A (ko) * 2000-08-24 2002-03-04 민경윤 마크로라이드계 항생제의 경구투여용 조성물 및 이의 제조방법
AU2004270188B8 (en) * 2003-09-03 2010-04-29 Mallinckrodt Inc. Granular sustained release preparation and production thereof
CN100415297C (zh) * 2006-08-28 2008-09-03 浙江大学 基于阳离子交换树脂的锌补充剂的制备方法
CN100411629C (zh) * 2006-08-28 2008-08-20 浙江大学 一种缓释型补铁剂的制备方法
EP2500016A1 (en) 2011-03-18 2012-09-19 Laboratorios Del. Dr. Esteve, S.A. Doxylamine resinate complex
WO2015076821A1 (en) * 2013-11-22 2015-05-28 Tris Pharma, Inc. Novel clonidine formulation
US11918689B1 (en) 2020-07-28 2024-03-05 Tris Pharma Inc Liquid clonidine extended release composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
FR2634377B1 (fr) * 1988-06-30 1991-09-27 Cortial Nouvelle forme pharmaceutique a liberation prolongee a base d'un complexe resine-principe actif
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes

Also Published As

Publication number Publication date
NO932212L (no) 1993-08-20
FI932842A0 (fi) 1993-06-18
WO1992011038A1 (en) 1992-07-09
SK59493A3 (en) 1993-11-10
NO932212D0 (no) 1993-06-16
NZ241097A (en) 1994-11-25
CN1063221A (zh) 1992-08-05
HU9301819D0 (en) 1993-09-28
FI932842A (fi) 1993-06-18
MX9102753A (es) 1992-06-30
AU9168791A (en) 1992-07-22
CA2098200A1 (en) 1992-06-21
JPH06504059A (ja) 1994-05-12
CZ119793A3 (en) 1994-01-19
IE914513A1 (en) 1992-07-01
BR9107173A (pt) 1993-11-16
AU663695B2 (en) 1995-10-19
PT99912A (pt) 1993-01-29
HUT74642A (en) 1997-01-28
EP0563294A1 (en) 1993-10-06

Similar Documents

Publication Publication Date Title
IE893537L (en) Sustained release drug-resin complexes
MY107811A (en) Polyamine drug-resin complexes
NO830948L (no) Oralt administrerbare farmasoeytiske preparater.
ZA909685B (en) Pharmaceutical compositions
FI935314A (fi) Farmaceutisk baerande
DE69710757D1 (de) Milnacipranhaltige darreichungsform mit verzögerter wirkstoffabgabe
CA2038672A1 (en) Dosage form for delivering drug to the intestine
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
CA2138122A1 (en) Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach and breast cancer
YU58902A (sh) Oralne formulacije opijatnog agonista otporne na mehaničke, termičke i/ili hemijske promene fizičkih osobina doznog oblika
NZ337216A (en) controlled-release microgranules containing cisplatin having a mean particle size of 0.4-1.5mm
GB9413951D0 (en) A novel drug delivery system
CA2273353A1 (en) Galenic composition containing opioid antagonists
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
FR2550944B1 (fr) Association pharmaceutique a base d'anticorps anticellules tumorales et de conjugues cytotoxiques, appropriee notamment pour le traitement des cancers
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
RU93043627A (ru) Фармацевтическая композиция, содержащая комплекс из смолы и полиаминового лекарственного препарата
ATE240097T1 (de) Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten
TH12562A (th) สารเชิงซ้อนเรซิน-ยาโพลิแอมีน
TH12562EX (th) สารเชิงซ้อนเรซิน-ยาโพลิแอมีน
EP0375649A3 (en) Swelling-controlled oral delivery system for drugs
IL103676A0 (en) Pharmaceutical compositions containing hemoglobins as drug delivery agents and methods for the preparation thereof
IL113359A (en) Polysaccharide drug delivery matrix and slow release pharmaceutical preparation containing it
GEP20022646B (en) Use Of Microparticles Having A Protein And An Antibody Adsorbed Thereon For Preparing A Pharmaceutical Composition For Intranasal Administration